Related Experiment Videos
A CD4+ CD56+ natural killer-like T-cell systemic lymphoma with haemorrhagic cutaneous manifestations
The British Journal of Dermatology
|March 17, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09).
European journal of cancer care·2016
A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss setting.
The British journal of dermatology·2015
Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design.
Breast (Edinburgh, Scotland)·2011
Trastuzumab beyond progression: a cost-utility analysis.
Annals of oncology : official journal of the European Society for Medical Oncology·2010
Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02).
Annals of oncology : official journal of the European Society for Medical Oncology·2009
Efficacy and Safety of Risankizumab in Paediatric Patients With Psoriasis in the OptIMMize-1 Phase III Study.
The British journal of dermatology·2026
Upadacitinib for Palmoplantar Pustulosis: An Open-label, Assessor-blinded Feasibility Study Using Historic Control Data (JAKPPPOT).
The British journal of dermatology·2026
Sustained response (ORR4) as an on-treatment prognostic marker in mogamulizumab-treated mycosis fungoides and Sézary syndrome: the FIL-MOGA study.
The British journal of dermatology·2026
Determinants of real-world sunscreen effectiveness: from ultraviolet radiation photobiology to human behaviour.
The British journal of dermatology·2026
Beyond the Surface of Long-term Survival in Stage IV Melanoma: A Multicenter Cross-sectional Study.
The British journal of dermatology·2026
Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.
Pharmaceuticals (Basel, Switzerland)·2026
Synergistic Regulation of Tumor Immunity by Integrins and Lectins: From Molecular Mechanisms to Dual-Targeted Therapy.
International journal of molecular sciences·2026